PARSIPPANY, N.J., Feb. 20, 2026 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Scotiabank Global Energy Conference on February 25, 2026; the Raymond James Institutional Investor Conference on March 2-3, 2026; and the Wolfe Research Refining Conference on March 5, 2026.

PBF Energy Inc. (NYSE: PBF - Get Free Report) saw some unusual options trading on Thursday. Stock traders acquired 64,035 put options on the company. This is an increase of 3,175% compared to the typical daily volume of 1,955 put options. PBF Energy Price Performance Shares of NYSE PBF opened at $33.90 on Friday. The stock

PBF beats Q4 estimates as higher refining margins and lower costs lift earnings despite a revenue dip.

PBF Energy (NYSE: PBF) executives used the company's fourth-quarter 2025 earnings call to highlight progress toward restarting its Martinez, California refinery, point to improving crude oil differentials as a key earnings lever, and outline additional cost-reduction targets under its Refinery Business Improvement (RBI) program. Martinez restart: construction nearly complete, operations targeted by early March Chief Executive

PBF Energy Inc. (PBF) Q4 2025 Earnings Call Transcript

PBF Energy (PBF) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to a loss of $2.82 per share a year ago.

Fourth quarter income from operations of $128.0 million (excluding special items, fourth quarter income from operations of $99.4 million) Full year loss from operations of $54.3 million (excluding special items, full year loss from operations of $479.5 million) Declares quarterly dividend of $0.275 per share Martinez refinery restart on schedule PARSIPPANY, N.J., Feb. 12, 2026 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today reported fourth quarter 2025 income from operations of $128.0 million as compared to loss from operations of $383.2 million for the fourth quarter of 2024.

Stock News Novo sues Hims over compounded weight-loss drugs: Novo Nordisk (NVO) filed suit to stop Hims and Hers Health (HIMS) from selling compounded semaglutide

Guru Stock PicksChuck Royce has made the following transactions:Reduce in NATL by 11.01%Sold out in DENNAdd in SXC by 106.69%New position in AZZKen Fisher has m

PBF Energy (PBF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.